KEYNOTE: REMAP ILD - Lessons to REMAP PAH

13 February 2026

Presented at PVRI 2026 Congress by Gisli Jenkins, Imperial College London

Summary

REMAP ILD trials play a crucial role in addressing PH and the complexities of fibrotic interstitial lung diseases. The focus is on adaptive platform trials, patient recruitment, and collaboration among healthcare systems. Innovative trial designs are necessary to enhance patient care, while funding challenges and inclusivity in clinical trials are essential for benefiting a wider patient population.

 

Generated with AI, edited by PVRI

Our speaker

Gisli Jenkins, Imperial College London
Share:

Other materials on this topic